Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Breaking Insights

  • Breaking Insights
    Highlights from Recent Cancer Literature
    Cancer Res March 1 2019 79 (5) 877-878;

Reviews

  • Reviews
    Deoxyribozymes as Catalytic Nanotherapeutic Agents
    Levon M. Khachigian
    Cancer Res March 1 2019 79 (5) 879-888; DOI:10.1158/0008-5472.CAN-18-2474

  • Reviews
    NRF2 Activation in Cancer: From DNA to Protein
    Erica W. Cloer, Dennis Goldfarb, Travis P. Schrank, Bernard E. Weissman and Michael B. Major
    Cancer Res March 1 2019 79 (5) 889-898; DOI:10.1158/0008-5472.CAN-18-2723

Priority Report

  • Priority Report
    HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
    Elin M.V. Forsberg, Mattias F. Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Marco Donia, Inge Marie Svane, Ola Nilsson, Lars Ny, Lisa M. Nilsson and Jonas A. Nilsson
    Cancer Res March 1 2019 79 (5) 899-904; DOI:10.1158/0008-5472.CAN-18-3158

    These findings demonstrate that a novel humanized mouse model can help clinical translation of CAR-T cells against uveal and cutaneous melanoma that do not respond to TIL therapy or immune checkpoint blockade.

Genome and Epigenome

  • Genome and Epigenome | AuthorChoice
    Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
    Pauline J. Beckmann, Jon D. Larson, Alex T. Larsson, Jason P. Ostergaard, Sandra Wagner, Eric P. Rahrmann, Ghaidan A. Shamsan, George M. Otto, Rory L. Williams, Jun Wang, Catherine Lee, Barbara R. Tschida, Paramita Das, Adrian M. Dubuc, Branden S. Moriarity, Daniel Picard, Xiaochong Wu, Fausto J. Rodriguez, Quincy Rosemarie, Ryan D. Krebs, Amy M. Molan, Addison M. Demer, Michelle M. Frees, Anthony E. Rizzardi, Stephen C. Schmechel, Charles G. Eberhart, Robert B. Jenkins, Robert J. Wechsler-Reya, David J. Odde, Annie Huang, Michael D. Taylor, Aaron L. Sarver and David A. Largaespada
    Cancer Res March 1 2019 79 (5) 905-917; DOI:10.1158/0008-5472.CAN-18-1261

    A transposon-induced mouse model identifies several novel genetic drivers and potential therapeutic targets in medulloblastoma and CNS-PNET.

  • Genome and Epigenome
    Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition
    Praveen Rajendran, Gavin Johnson, Li Li, Ying-Shiuan Chen, Mohaiza Dashwood, Nhung Nguyen, Ahmet Ulusan, Furkan Ertem, Mutian Zhang, Jia Li, Deqiang Sun, Yun Huang, Shan Wang, Hon-Chiu Leung, David Lieberman, Laura Beaver, Emily Ho, Mark Bedford, Kyle Chang, Eduardo Vilar and Roderick Dashwood
    Cancer Res March 1 2019 79 (5) 918-927; DOI:10.1158/0008-5472.CAN-18-2003

    These results highlight the competition that exists among the “readers” of acetylated histone and nonhistone proteins and provide a mechanistic basis for potential new therapeutic avenues involving epigenetic combination treatments.

Molecular Cell Biology

  • Molecular Cell Biology
    PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1
    Cheng Zhang, Like Qu, Shenyi Lian, Lin Meng, Li Min, Jiafei Liu, Qian Song, Lin Shen and Chengchao Shou
    Cancer Res March 1 2019 79 (5) 928-940; DOI:10.1158/0008-5472.CAN-18-0520

    Dephosphorylation of FZR1 by PRL-3 facilitates the activity of APC/CFZR1 by destabilizing AURKA, thus influencing aggressive characteristics and overall progression of colorectal cancer.

  • Molecular Cell Biology
    miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features
    Yuanzhuo Gu, Xiyang Wei, Yulin Sun, Hongjun Gao, Xin Zheng, Linda L. Wong, Ling Jin, Niya Liu, Brenda Hernandez, Karolina Peplowska, Xiaohang Zhao, Qi-Min Zhan, Xin-Hua Feng, Zhao-You Tang and Junfang Ji
    Cancer Res March 1 2019 79 (5) 941-953; DOI:10.1158/0008-5472.CAN-18-1675

    miR-192-5p and its regulatory pathway is significantly abolished in multiple groups of HCC expressing high levels of CSC markers, which may represent a key event for hepatic carcinogenesis.

  • Molecular Cell Biology
    Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion
    Yi Liu, Yasunori Deguchi, Rui Tian, Daoyan Wei, Ling Wu, Weidong Chen, Weiguo Xu, Min Xu, Fuyao Liu, Shen Gao, Jonathan C. Jaoude, Sarah P. Chrieki, Micheline J. Moussalli, Mihai Gagea, Jeffrey Morris, Russell R. Broaddus, Xiangsheng Zuo and Imad Shureiqi
    Cancer Res March 1 2019 79 (5) 954-969; DOI:10.1158/0008-5472.CAN-18-1790

    These findings address long-standing, important, and unresolved questions related to the potential role of PPARD in APC mutation-dependent colorectal tumorigenesis by showing PPARD activation enhances APC mutation-dependent tumorigenesis.

Tumor Biology and Immunology

  • Tumor Biology and Immunology
    Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations
    Dustin J. Flanagan, Nick Barker, Natasha S. Di Costanzo, Elizabeth A. Mason, Austin Gurney, Valerie S. Meniel, Sarah Koushyar, Chloe R. Austin, Matthias Ernst, Helen B. Pearson, Alex Boussioutas, Hans Clevers, Toby J. Phesse and Elizabeth Vincan
    Cancer Res March 1 2019 79 (5) 970-981; DOI:10.1158/0008-5472.CAN-18-2095

    The Wnt receptor Fzd7 plays an essential role in gastric tumorigenesis irrespective of Apc mutation status, therefore targeting Wnt/Fzd7 may be of therapeutic benefit to patients with gastric cancer.

Translational Science

  • The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
    Translational Science
    The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
    Ikbale El Ayachi, Iram Fatima, Peter Wend, Jackelyn A. Alva-Ornelas, Stephanie Runke, William L. Kuenzinger, Julio Silva, Wendy Silva, Joseph K. Gray, Stephan Lehr, Hilaire C. Barch, Raisa I. Krutilina, Andrew C. White, Robert Cardiff, Lisa D. Yee, Lily Yang, Ruth M. O'Regan, William E. Lowry, Tiffany N. Seagroves, Victoria Seewaldt, Susan A. Krum and Gustavo A. Miranda-Carboni
    Cancer Res March 1 2019 79 (5) 982-993; DOI:10.1158/0008-5472.CAN-18-1069

    These findings reveal targeting the WNT signaling pathway as a potential therapeutic strategy in triple-negative breast cancer.

  • Translational Science
    Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition
    Matthew L. Hemming, Matthew A. Lawlor, Jessica L. Andersen, Timothy Hagan, Otari Chipashvili, Thomas G. Scott, Chandrajit P. Raut, Ewa Sicinska, Scott A. Armstrong, George D. Demetri and James E. Bradner
    Cancer Res March 1 2019 79 (5) 994-1009; DOI:10.1158/0008-5472.CAN-18-1888

    Expression and activity of mutant KIT is essential for driving the majority of GIST neoplasms, which can be therapeutically targeted using BET bromodomain inhibitors.

Resource Report

  • Resource Report
    esiCancer: Evolutionary In Silico Cancer Simulator
    Darlan Conterno Minussi, Bernardo Henz, Mariana dos Santos Oliveira, Eduardo C. Filippi-Chiela, Manuel M. Oliveira and Guido Lenz
    Cancer Res March 1 2019 79 (5) 1010-1013; DOI:10.1158/0008-5472.CAN-17-3924

    This study provides a customizable and hands-on simulation tool to model the effect of diverse types of genomic alterations on the fate of tumor cells.

Corrections

  • Corrections | Free Article
    Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity
    Akshata R. Udyavar, David J. Wooten, Megan Hoeksema, Mukesh Bansal, Andrea Califano, Lourdes Estrada, Santiago Schnell, Jonathan M. Irish, Pierre P. Massion and Vito Quaranta
    Cancer Res March 1 2019 79 (5) 1014-1014; DOI:10.1158/0008-5472.CAN-19-0069

  • Corrections | Free Article
    Correction: Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
    Shasha Tao, Shue Wang, Seyed Javad Moghaddam, Aikseng Ooi, Eli Chapman, Pak K. Wong and Donna D. Zhang
    Cancer Res March 1 2019 79 (5) 1015-1015; DOI:10.1158/0008-5472.CAN-19-0070

Retraction

  • Retraction | Free Article
    Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells
    Sudhakar Ammanamanchi, Manoranjani P.M. Tillekeratne, Tien C. Ko and Michael G. Brattain
    Cancer Res March 1 2019 79 (5) 1016-1016; DOI:10.1158/0008-5472.CAN-19-0071

Back to top
PreviousNext
Cancer Research: 79 (5)
March 2019
Volume 79, Issue 5
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

Issue Highlights

  • Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations
  • The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
  • esiCancer: Evolutionary In Silico Cancer Simulator

Jump to

  • Breaking Insights
  • Reviews
  • Priority Report
  • Genome and Epigenome
  • Molecular Cell Biology
  • Tumor Biology and Immunology
  • Translational Science
  • Resource Report
  • Corrections
  • Retraction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Towards Multidrug Adaptive Therapy
  • IL1β Promotes Immune Suppression in Pancreatic Cancer
  • SHP2 in Macrophages and Tumor Immunosuppression
  • Metabolomic Gradients in Glioblastoma Models
  • ATM Loss and Therapeutic Sensitivities in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement